1. Agnati, L.F., Fuxe, K., Calza, L., Benfenati, F., Cavicchioli, L., Toffano, G., and Goldstein, M.: Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Acta Physiol Scand. (1983), 119: 347–363, 1983.
2. Ahmed, F.R., and Bagli, J.: Troponoid. V. Crystallographic studies on AY-27110—a dopamine agonist of the troponylpiperazine series. Can. J. Chem.
60, 2687–2691 (1982).
3. Calne, D.B., Teychenne, P.F., Calveria, L.E., etal.: Bromocriptine in Parkin-sonism. Br. Med. J.
4, 442–444 (1974).
4. Corrodi, H., Fuxe, K., Hokfelt, T., Lidbrink, P., and Ungerstedt, U.: Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neurons. J. Pharm. Pharmacol.
25, 409–411 (1973).
5. Enz, A.: Biphasic influence of a 8α-amino ergoline, CU 32-085, on striatal dopamine synthesis and turnover in vivo in the rat. Life Sci. 29, 2221–223A (1981).